EXHIBIT 99.1

Date:          January 21, 2004
Contact:  Mendo Akdag, CEO
Phone:         (954) 979-5995
Fax:      (954) 971-0544

PETMED EXPRESS D/B/A 1-800-PETMEDS ANNOUNCES THE LISTING OF
ITS STOCK ON THE NASDAQ NATIONAL MARKET

Pompano Beach, Florida, January 21, 2004 - Menderes Akdag,
Chief Executive Officer of PetMed Express, Inc., announced
today the achievement of a major milestone for the company.
"We are very pleased to announce that our application to
list our common stock on the NASDAQ National Market has been
approved, and we anticipate trading on the National Market
beginning on Friday, January 23, 2004 under our symbol
"PETS," Mr. Akdag stated.  Prior to the upcoming move to the
NASDAQ National Market, PetMed Express shares have been
traded on the over-the-counter bulletin board.

"This approval to trade on the NASDAQ National Market
validates our significant progress over the past two and a
half years and our continued commitment as a public company.
We expect that trading on the NASDAQ National Market will
greatly increase the number of investors who have been
attracted to our ongoing positive performance, and will
provide a more stable market for our stock. The listing
should also significantly increase our visibility with
brokers and institutions as well as with the media, adding
enhanced value to our stock through the increased
distribution and liquidity," said Mr. Akdag.

Founded in 1996, PetMed Express is America's largest pet
pharmacy, delivering prescription and non-prescription pet
medications, health and nutritional supplements at
competitive prices through the PetMed Express catalog,
customer service representatives, and on the Internet
through its website at www.1800PetMeds.com.

This press release may contain "forward-looking" statements,
as defined in the Private Securities Litigation Reform Act
of 1995 or by the Securities and Exchange Commission, that
involve a number of risk and uncertainties, including the
Company's ability to meet the objectives included in its
business plan.  Important factors that could cause results
to differ materially from those indicated by such "forward-
looking" statements are set forth in Management's Discussion
and Analysis or Plan of Operations in the PetMed Express
Annual Report on Form 10-KSB for the year ended March 31,
2003.

For investment relations contact PetMed Express, Inc.,
Pompano Beach, Mendo Akdag, CEO, 954-979-5995.

                             ###


                       99.1 page 1 - 1